The stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion were both amplified in PTEN-deficient prostate cancer due to the abnormal activation of the IL-8/CXCR2 signaling pathway [10]. This evidence concerns the gene CXCR2 and prostate cancer.